ArticleInternational journal of molecular sciences2026
Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and Inflammation.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic fibrosis is a multi-organ disease in which pancreatic involvement occurs early and contributes significantly to disease progression. Despite this, most mechanistic and pharmacological studies of CFTR have been conducted in airway epithelia, while pancreatic duct models remain relatively poorly represented. In this study, we establish CAPAN-1 cells as a reproducible in vitro model of pancreatic duct epithelium and assess wild-type CFTR function under basal and inflammatory conditions. Cells were cultured as polarized monolayers and analysed for transepithelial conductance, ion transport, luminal fluid pH regulation, and microviscosity. CFTR activity was stimulated with forskolin and further modulated using the potentiator ivacaftor (VX770) and the correctors tezacaftor (VX661) and elexacaftor (VX445), while specificity was confirmed with the CFTR inhibitor PPQ102. Inflammation was induced by lipopolysaccharide (LPS). CAPAN-1 cells formed a functional epithelium. CFTR activation increased epithelial conductance, promoted apical surface fluid alkalinization, and reduced apical surface fluid microviscosity, while PPQ102 consistently inhibited these effects. CFTR modulators enhanced functional responses in the presence of forskolin, although with moderate magnitude, consistent with wild-type CFTR expression. LPS exposure altered epithelial properties, increasing baseline conductance and impairing pH regulation, and induced secretion of pro-inflammatory cytokines. Notably, inflammatory stimulation did not abolish CFTR modulator responses, although it modified some downstream epithelial outputs. These findings identify CAPAN-1 cells as a physiologically relevant model for investigating CFTR function in the pancreatic duct environment and show that CFTR modulator responses are maintained, although functionally reshaped, under inflammatory conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.